Hims & Hers Health, Inc. (HIMS) stock
HIMSNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30191% above fair value
$19.73+0.00 (0.00%)
Close on Nov 13, 2026Market cap $4.60BP/E –Yield –
Hims & Hers Health EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Hims & Hers Health's EPS for the twelve months ending Sep 30, 2026 was -$0.83, down 253.7% year over year. For fiscal 2025 it was $0.51, down 3.8% from the year before. The highest annual figure on record is $0.53 in fiscal 2024.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0.51 | -3.8% |
| FY2024 | Dec 31, 2024 | $0.53 | – |
| FY2023 | Dec 31, 2023 | -$0.11 | – |
| FY2022 | Dec 31, 2022 | -$0.32 | – |
| FY2021 | Dec 31, 2021 | -$0.58 | – |
| FY2020 | Dec 31, 2020 | -$0.51 | – |
| FY2019 | Dec 31, 2019 | -$2.07 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$0.14 | -333.3% |
| Q2 FY2026 | Jun 30, 2026 | -$0.37 | -317.6% |
| Q1 FY2026 | Mar 31, 2026 | -$0.40 | -300.0% |
| Q4 FY2025 | Dec 31, 2025 | $0.08 | -27.3% |
| Q3 FY2025 | Sep 30, 2025 | $0.06 | -81.3% |
| Q2 FY2025 | Jun 30, 2025 | $0.17 | +183.3% |
| Q1 FY2025 | Mar 31, 2025 | $0.20 | +300.0% |
| Q4 FY2024 | Dec 31, 2024 | $0.11 | +1000.0% |
| Q3 FY2024 | Sep 30, 2024 | $0.32 | – |
| Q2 FY2024 | Jun 30, 2024 | $0.06 | – |
| Q1 FY2024 | Mar 31, 2024 | $0.05 | – |
| Q4 FY2023 | Dec 31, 2023 | $0.01 | – |
| Q3 FY2023 | Sep 30, 2023 | -$0.04 | – |
| Q2 FY2023 | Jun 30, 2023 | -$0.03 | – |
| Q1 FY2023 | Mar 31, 2023 | -$0.05 | – |
| Q4 FY2022 | Dec 31, 2022 | -$0.05 | – |
| Q3 FY2022 | Sep 30, 2022 | -$0.09 | – |
| Q2 FY2022 | Jun 30, 2022 | -$0.10 | – |
| Q1 FY2022 | Mar 31, 2022 | -$0.08 | – |
| Q4 FY2021 | Dec 31, 2021 | -$0.15 | – |
| Q3 FY2021 | Sep 30, 2021 | -$0.08 | – |
| Q2 FY2021 | Jun 30, 2021 | -$0.05 | – |
| Q1 FY2021 | Mar 31, 2021 | -$0.34 | – |
| Q4 FY2020 | Dec 31, 2020 | -$0.15 | – |
| Q3 FY2020 | Sep 30, 2020 | -$0.16 | – |
| Q2 FY2020 | Jun 30, 2020 | -$0.03 | – |
| Q1 FY2020 | Mar 31, 2020 | -$0.17 | – |
| Q2 FY2019 | Jun 30, 2019 | $0.00 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?